Mercaptopropionic Acid

Mercaptopropionic Acid

SCHEMBL552238

O=C(O)CCS.O=C(O)CCS.OCCCCO

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.62
FFAR1 O14842 1/20 0.62
FFAR4 Q5NUL3 1/20 0.62
CAMK2A Q9UQM7 1/20 0.60
FOLH1 Q04609 5/20 0.55
ACE P12821 1/20 0.52
LMNA P02545 3/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
PMP22 Q01453 1/20 0.43
ALKBH5 Q6P6C2 1/20 0.42
SUCNR1 Q9BXA5 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
ENPEP Q07075 3/20 0.39
ANPEP P15144 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mercaptopropionic Acid SCHEMBL15380254 0.97 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AFOLH1
1,5-Pentanediol SCHEMBL29088658 0.97 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL15379275 0.97 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AFOLH1
1,6-Hexanediol SCHEMBL998036 0.97 GPR84 (0.67) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL25301983 0.95 FOLH1 (0.64) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL997923 0.94 CAMK2A (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL2227412 0.88 ACE (0.57) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL30556234 0.88 ACE (0.57) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL28714218 0.88 ACE (0.57) GPR84FFAR1FFAR4CAMK2AFOLH1
Mercaptopropionic Acid SCHEMBL331156 0.88 ACE (0.57) GPR84FFAR1FFAR4CAMK2AFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES LANNRAY ADVANCED MAT CO LTD (CN) 2026-05-14 US claimed
EP-4731691-A1 CURABLE COMPOSITION HAVING AN ALDEHYDE-FUNCTIONAL POLYMER Sika Technology AG (CH) 2026-04-29 EP claimed
EP-3275911-B1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS HOYA LENS THAILAND LTD (TH) 2025-07-02 EP claimed
WO-2024261009-A1 CURABLE COMPOSITION HAVING AN ALDEHYDE-FUNCTIONAL POLYMER SIKA TECHNOLOGY AG (CH) 2024-12-26 WO claimed
EP-4480978-A1 CURABLE COMPOSITION CONTAINING ALDEHYDE FUNCTIONAL POLYMER Sika Technology AG (CH) 2024-12-25 EP claimed
WO-2024188359-A1 POLYTHIOL COMPOSITION AND USE THEREOF 益丰新材料股份有限公司 2024-09-19 WO claimed
US-20240225977-A9 NAIL POLISH GLUE AND PREPARATION METHOD AND APPLICATION THEREOF Lu, Yang (CN) 2024-07-11 US claimed
US-12023640-B2 Aqueous dispersion of microcapsules, and uses thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2024-07-02 US claimed
US-20240130943-A1 NAIL POLISH GLUE AND PREPARATION METHOD AND APPLICATION THEREOF Lu, Yang (CN) 2024-04-25 US claimed
CN-113956477-B Curing composition and application thereof, and cured polymer material and preparation method and application thereof 中国石油化工股份有限公司 2023-10-13 CN claimed
US-20180100033-A1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS HOYA LENS THAILAND LTD. (TH) 2018-04-12 US claimed
EP-2848641-B1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORP (JP) 2018-02-28 EP claimed
EP-3275911-A1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS Hoya Lens Thailand Ltd. (TH) 2018-01-31 EP claimed
US-9527948-B2 Polymerizable composition, optical article obtained therefrom and method for the production of said optical article MITSUI CHEMICALS, INC. (JP) 2016-12-27 US claimed
US-20160000484-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE REPAIR TECHNOLOGIES SWEDEN AB (SE) 2016-01-07 US claimed
US-20150148495-A1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORPORATION (JP) 2015-05-28 US claimed
EP-2848641-A1 METHOD FOR PRODUCING RUBBER MOLDING Nichias Corporation (JP) 2015-03-18 EP claimed
US-20120308532-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE PROPPABORT AB (SE) 2012-12-06 US claimed
WO-2011048077-A2 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE REPAIR TECHNOLOGIES SWEDEN AB (SE) 2011-04-28 WO claimed
US-7268197-B2 Water- and oil-repellent fluorourethanes and fluoroureas 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260133459-A1 LOW-TEMPERATURE SOLID POLYMER ELECTROLYTE FOR ELECTROCHROMIC DEVICES EEF2, PHF2, EIF4E GPR84 4818/4885FFAR1 4322/4885FFAR4 3727/4885
US-20120308532-A1 COMPOSITION FOR THE TREATMENT OF A BONE FRACTURE VCL, BMP2, SHC1 GPR84 1754/4885FFAR1 1675/4885FFAR4 1039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.